Table 2 Unadjusted events rate (per 1000 patient-years) by stage of chronic kidney disease among patients with diabetes, 2011–2013
| Â | ESRD | MI | CHF | |||||||||
CKD Stage | CKD Stage | CKD Stage | ||||||||||
Non-DKD | 1–2 | 3 | 4–5 | Non-DKD | 1–2 | 3 | 4–5 | Non-DKD | 1–2 | 3 | 4–5 | |
Overall | 0.5 | 4.0 | 13.1 | 152.8 | 4.6 | 7.6 | 15.3 | 32.2 | 7.1 | 28.4 | 74.6 | 199.9 |
Ages, yrs., % | ||||||||||||
 18–44 | 0.3 | 5.0 | 23.9 | 252.1 | 1.9 | 4.2 | 10.2 | 18.1 | 2.8 | 17.0 | 70.7 | 148.3 |
 45–54 | 0.4 | 4.0 | 16.7 | 179.0 | 4.3 | 6.9 | 15.5 | 30.4 | 5.3 | 23.8 | 71.9 | 186.9 |
 55–59 | 0.6 | 3.5 | 12.2 | 142.6 | 5.4 | 7.4 | 14.8 | 31.0 | 8.2 | 26.2 | 69.0 | 199.5 |
 60–64 | 0.8 | 3.9 | 10.6 | 127.2 | 6.3 | 9.9 | 16.2 | 37.0 | 11.7 | 39.4 | 80.0 | 218.3 |
Sex | ||||||||||||
 Male | 0.6 | 4.5 | 14.3 | 165.9 | 5.9 | 8.6 | 16.7 | 32.6 | 7.8 | 31.5 | 80.4 | 206.0 |
 Female | 0.4 | 3.2 | 11.4 | 135.7 | 3.2 | 6.2 | 13.4 | 31.7 | 6.4 | 23.9 | 66.3 | 191.7 |
No. comorbid conditions | ||||||||||||
 0 | 0.4 | 0.0 | 5.3 | 172.9 | 4.5 | 8.4 | 4.0 | 32.8 | 3.5 | 10.0 | 11.9 | 92.6 |
 1 | 0.3 | 1.1 | 3.7 | 137.4 | 3.7 | 5.3 | 11.1 | 19.7 | 3.3 | 3.5 | 21.0 | 90.5 |
 2 | 0.4 | 1.6 | 4.0 | 133.2 | 4.2 | 5.1 | 8.4 | 22.1 | 4.6 | 7.6 | 16.6 | 98.0 |
 3 | 0.6 | 3.3 | 7.7 | 133.1 | 5.2 | 5.3 | 10.3 | 23.6 | 9.1 | 11.7 | 26.7 | 111.8 |
  ≥ 4 | 1.8 | 6.7 | 20.0 | 164.4 | 9.0 | 11.0 | 20.7 | 38.3 | 35.2 | 57.5 | 123.7 | 261.0 |
| Â | Stroke | Infection | Â | |||||||||
Non-DKD | 1–2 | 3 | 4–5 | Non-DKD | 1–2 | 3 | 4–5 |  |  |  |  | |
Overall | 4.6 | 9.0 | 14.5 | 25.2 | 22.7 | 50.1 | 84.5 | 179.6 | Â | Â | Â | Â |
Ages, yrs., % | ||||||||||||
 18–44 | 1.7 | 5.2 | 9.4 | 23.6 | 20.6 | 59.9 | 95.8 | 201.0 |  |  |  |  |
 45–54 | 3.5 | 8.1 | 14.4 | 26.3 | 20.0 | 47.6 | 91.7 | 184.5 |  |  |  |  |
 55–59 | 5.4 | 9.7 | 14.1 | 25.0 | 23.5 | 45.8 | 77.1 | 167.3 |  |  |  |  |
 60–64 | 7.3 | 10.8 | 15.5 | 25.1 | 27.2 | 52.1 | 84.5 | 181.0 |  |  |  |  |
Sex | ||||||||||||
 Male | 5.0 | 8.3 | 14.6 | 25.3 | 20.7 | 43.0 | 80.0 | 168.6 |  |  |  |  |
 Female | 4.2 | 9.9 | 14.3 | 25.1 | 25.0 | 60.6 | 91.0 | 194.5 |  |  |  |  |
No. comorbid conditions | ||||||||||||
 0 | 3.8 | 3.3 | 10.6 | 11.9 | 14.6 | 21.7 | 38.3 | 59.7 |  |  |  |  |
 1 | 3.2 | 3.5 | 9.1 | 20.1 | 14.5 | 15.5 | 34.3 | 99.5 |  |  |  |  |
 2 | 3.9 | 5.6 | 7.5 | 21.0 | 17.8 | 26.5 | 33.3 | 96.2 |  |  |  |  |
 3 | 5.5 | 6.7 | 9.3 | 20.5 | 29.7 | 31.7 | 43.0 | 112.8 |  |  |  |  |
  ≥ 4 | 12.6 | 14.0 | 20.0 | 28.3 | 77.9 | 85.0 | 127.8 | 227.7 |  |  |  |  |